Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...

Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached its second release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...

Dalton Cooper is the Managing Editor of GameRant. Dalton has been writing about video games professionally since 2011. Having written thousands of game reviews and articles over the course of his ...

One of Roblox's many hit Jujutsu Kaisen games, Jujutsu Infinite can be a tough game, though our codes will help you out. These codes will get you plenty of free Spins, helping you on your way to ...

This essay and interview appear in this week’s The Book Pages newsletter. For more information and book coverage, sign up for the free newsletter. Years ago, I taught English as a Second Language at a ...

Frequent fliers with big grocery bills or multi-vehicle households will be able to make the most of this travel rewards credit card. Many or all of the products on this page are from partners who ...

Clint Proctor is a lead editor with the credit cards and travel rewards team at Forbes Advisor. He has five years of experience in personal finance journalism and has contributed to a variety of ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...